"10.1371_journal.pmed.1001977","plos medicine","2016-03-24T00:00:00Z","Kathryn E Lafond; Harish Nair; Mohammad Hafiz Rasooly; Fátima Valente; Robert Booy; Mahmudur Rahman; Paul Kitsutani; Hongjie Yu; Guiselle Guzman; Daouda Coulibaly; Julio Armero; Daddi Jima; Stephen R C Howie; William Ampofo; Ricardo Mena; Mandeep Chadha; Ondri Dwi Sampurno; Gideon O Emukule; Zuridin Nurmatov; Andrew Corwin; Jean Michel Heraud; Daniel E Noyola; Radu Cojocaru; Pagbajabyn Nymadawa; Amal Barakat; Adebayo Adedeji; Marta von Horoch; Remigio Olveda; Thierry Nyatanyi; Marietjie Venter; Vida Mmbaga; Malinee Chittaganpitch; Tran Hien Nguyen; Andros Theo; Melissa Whaley; Eduardo Azziz-Baumgartner; Joseph Bresee; Harry Campbell; Marc-Alain Widdowson; Global Respiratory Hospitalizations—Influenza Proportion Positive (GRIPP) Working Group","Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; School of Health Sciences, University of Tampere, Tampere, Finland; Centre for Global Health Research, University of Edinburgh, Edinburgh, United Kingdom; Public Health Foundation of India, New Delhi, India; Afghanistan National Public Health Institute, Ministry of Public Health, Kabul, Afghanistan; National Directorate of Public Health, Ministry of Health, Luanda, Angola; National Centre for Immunisation Research and Surveillance, The Childrens Hospital at Westmead, Westmead, New South Wales, Australia; Institute of Epidemiology, Disease Control and Research, Dhaka, Bangladesh; Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Centre for Disease Control and Prevention, Beijing, China; Caja Costarricense de Seguro Social, San José, Costa Rica; Pasteur Institut of Côte dIvoire, Abidjan, Côte dIvoire; Ministerio de Salud de El Salvador, San Salvador, El Salvador; Ethiopian Public Health Institute, Addis Ababa, Ethiopia; Medical Research Council Unit, Fajara, The Gambia; Department of Paediatrics, University of Auckland, Auckland, New Zealand; Centre for International Health, University of Otago, Dunedin, New Zealand; Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana; Ministerio de Salud Publica y Asistencia Social, Guatemala City, Guatemala; National Institute of Virology, Pune, India; National Institute of Health Research and Development, Jakarta, Indonesia; Centers for Disease Control and Prevention, Nairobi, Kenya; Ministry of Health, Bishkek, Kyrgyzstan; National Influenza Centre, Virology Unit, Institut Pasteur of Madagascar, Antananarivo, Madagascar; Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico; National Centre for Public Health, Chisinau, Republic of Moldova; National Influenza Center, Ulaanbaatar, Mongolia; Institut National dHygiène, Ministère de la Santé, Rabat, Morocco; Federal Ministry of Health, Abuja, Nigeria; Ministerio de Salud Publica y Bienestar Social, Asunción, Paraguay; Research Institute for Tropical Medicine, Manila, Philippines; Ministry of Health, Kigali, Rwanda; National Institute for Communicable Diseases, Johannesburg, South Africa; Zoonoses Research Unit, Department Medical Virology, University of Pretoria, Pretoria, South Africa; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; Ministry of Health, Dar es Salaam, Tanzania; National Institute of Health, Ministry of Public Health, Nonthaburi, Thailand; National Institute of Hygiene and Epidemiology, Hanoi, Viet Nam; Virology Laboratory, University Teaching Hospital, Lusaka, Zambia","Conceived and designed the experiments: KEL HN MAW. Performed the experiments: KEL MW EAB MAW. Analyzed the data: KEL HN EAB MAW. Contributed reagents/materials/analysis tools: KEL HN MW. Wrote the first draft of the manuscript: KEL. Contributed to the writing of the manuscript: MAW. Enrolled patients: MHR FV RB MR PK HY GG DC JA DJ SH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT GRIPP-WG. Agree with the manuscripts results and conclusions: KEL HN MHR FV RB MR PK HY GG DC JA DJ SRCH WA RM MCha ODS GOE ZN AC JMH DEN RC PN AB AA MvH RO TN MV VM MChi THN AT MW EAB JB HC MAW GRIPP-WG. All authors have read, and confirm that they meet, ICMJE criteria for authorship.","We have read the journals policy and have the following competing interests: DEN has participated on an influenza advisory board for Novartis. RB works with all major manufacturers of influenza vaccines in an advisory capacity, as a researcher on vaccines and as presenter of academic info at conferences, receiving support to travel and attend such conferences. The authors have declared that no other competing interests exist.","2016","03","Kathryn E Lafond","KEL",40,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
